Emcure Pharma Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 2.727916625
Author: Trendlyne DVM scores

Mid-range Performer

about

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

1927.60 72.90 (3.93%)

52.98% Gain from 52W Low

301.2K

NSE+BSE Volume

NSE 04 Sep, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

52.4 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

2,226

1Yr Price target upside is 15%

8 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

52.98% Gain from 52W Low

SWOT Analysis

Emcure Pharma Live Price Chart

Emcure Pharma Live Price Chart